• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    The role of the atypical cadherin Fat1 in the regulation of vascular smooth muscle cells during atherosclerosis

    Thumbnail
    Date
    2015
    Author
    Dunaway AItamirano, Charlene Marie
    Metadata
    Show full item record
    Abstract
    Fat1 is an atypical cadherin that controls vascular smooth muscle cell (SMC) growth and migration. After arterial injury, SMC-specific Fat1-knockout (fat1SMKO) mice exhibit exacerbated neointima formation with increased SMC proliferation and decreased SMC marker gene expression. In recent studies, we found that Fat1 expression colocalizes with SMCs in atherosclerotic lesions from apolipoprotein E-/- (Apoe-/-) mice. We hypothesize that Fat1 regulation of SMC activities is important in limiting atherogenesis. To test this, we generated fat1SMKO; Apoe-/- double-knockout (DKO) mice and assessed atherosclerosis after 24 weeks on a high fat diet, analyzing aortic roots and brachiocephalic arteries (BCA) for lesion area and immunohistochemical features. DKO mice (N=10) exhibited larger lesions with thicker fibrous caps and larger necrotic cores. Furthermore, DKO lesions displayed increased proliferation and SMC content. The intermediate filament protein vimentin was recently identified as a novel Fat1 interactor. Fat1 and vimentin expression colocalized within the fibrous cap area of atherosclerotic lesions. Moreover, Fat1-deficient SMCs and lesions exhibited increased vimentin levels, and knockdown studies suggest that vimentin plays a role in SMC growth. SMC Fat1 deficiency also resulted in increased beta-catenin levels and upregulation of beta-catenin target genes, Axin2 and Snail1. Concomitantly, SMC Fat1 deficiency caused reduced E-cadherin expression and promoter activity. In summary, Fat1-deficient SMCs undergo changes in expression of genes associated with epithelial-to-mesenchymal transition in proper epithelial cells. These findings suggest that components of this regulatory network are operative in SMCs, and controlled by Fat1, which promotes a state of quiescence in SMCs that opposes atherosclerotic lesion expansion.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:3663973
    https://hdl.handle.net/20.500.12202/1542
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University